The first Intercept Pharmaceuticals trade was made in Q3 2017.
Since then Ken Fisher bought shares five more times and sold shares on nine occasions. The investor completely sold their stake between Q4 2019 and Q1 2021.
Avg closing price
Price range
Sold -60 Thousand shares
Q1 2021
Avg closing price
$27.88
Price range
$19.33
-
$37.75
Sold 4.6% shares (-2.87 Thousand shares)
Q4 2020
Avg closing price
$33.14
Price range
$24.48
-
$42.47
Sold 6.4% shares (-4.27 Thousand shares)
Q3 2020
Avg closing price
$45.95
Price range
$39.09
-
$53.44
Sold 0.2% shares (-147 shares)
Q2 2020
Avg closing price
$77.25
Price range
$46.70
-
$92.04
Sold 10.6% shares (-7.96 Thousand shares)
Q1 2020
Avg closing price
$89.87
Price range
$48.35
-
$118.68
Sold 6.7% shares (-5.39 Thousand shares)
Q4 2019
Avg closing price
$89.53
Price range
$57.36
-
$124.10
Increased shares by 0.6% (+493 shares)
Q3 2019
Avg closing price
$67.15
Price range
$58.69
-
$80.46
Increased shares by 110.8% (+42.1 Thousand shares)
Q2 2019
Avg closing price
$89.50
Price range
$77.77
-
$120.68
Increased shares by 0.1% (+46 shares)
Q1 2019
Avg closing price
$109.26
Price range
$91.83
-
$120.68
Sold 1.3% shares (-511 shares)
Q4 2018
Avg closing price
$103.65
Price range
$85.79
-
$126.46
Sold 13.7% shares (-6.11 Thousand shares)
Q3 2018
Avg closing price
$105.82
Price range
$88.49
-
$127.55
Increased shares by 12.2% (+4.84 Thousand shares)
Q2 2018
Avg closing price
$73.22
Price range
$60.00
-
$85.67
Sold 0.3% shares (-100 shares)
Q1 2018
Avg closing price
$60.27
Price range
$52.72
-
$67.25
Increased shares by 196.6% (+26.4 Thousand shares)
Q4 2017